Effect of free radical scavenger on c-jun activation in rats with crush syndrome

Int J Clin Pharmacol Ther. 2013 Jul;51(7):600-5. doi: 10.5414/CP201846.

Abstract

Objectives: To evaluate the relationship between reactive oxygen species (ROS)-mediated kidney injuries and Jun N-terminal kinase (JNK) activity and the therapeutic effects of tempol in crush syndrome (CS) model rats.

Methods: Male Wister rats were randomly divided into sham operation group (SOG), CS groups (CS6G, CS12G and CS24G) and tempol treatment group (TG, a ROS scavenger). CS model rats were established by crushing the hind limbs of rats with 15 kg pressure for 6 hours, and inferior caval vein blood and kidney samples were harvested at 6, 12, 24 hours after removing crush pressure. In TG, 100 mg/kg tempol was intraperitoneally injected into CS model rats after withdraw of crush pressure. In SOG, rats were fixed on the board without any crush pressure. The activation of c-jun was determined by western blotting. Serological parameters and the content of malondialdehyde (MDA) in kidney tissues were determined by standard methods.

Results: Acute kidney injury reached the peak at 12 hours after the crush pressure. Compared with SOG, the content of phosphorylated c-jun was significantly higher in CSG and TG (p < 0.05), and the content of phosphorylated c-jun in the CSG was significantly higher than that in TG (p < 0.05). Interestingly, the changes of the MDA content in the kidney tissues of the 3 groups were similar to the changes of phosphorylated c-jun content.

Conclusion: ROS-mediated phosphorylation of c-jun may play important roles in the acute kidney injury of CS rats. Tempol can inhibit the phosphorylation of c-jun and alleviate the acute kidney injury.

MeSH terms

  • Acute Kidney Injury / drug therapy*
  • Acute Kidney Injury / etiology
  • Acute Kidney Injury / metabolism
  • Animals
  • Biomarkers / blood
  • Blotting, Western
  • Crush Syndrome / complications
  • Crush Syndrome / drug therapy*
  • Crush Syndrome / metabolism
  • Cyclic N-Oxides / administration & dosage
  • Cyclic N-Oxides / pharmacology*
  • Disease Models, Animal
  • Enzyme Activation
  • Free Radical Scavengers / administration & dosage
  • Free Radical Scavengers / pharmacology*
  • Injections, Intraperitoneal
  • JNK Mitogen-Activated Protein Kinases / metabolism*
  • Kidney / drug effects*
  • Kidney / metabolism
  • Lipid Peroxidation / drug effects
  • Male
  • Malondialdehyde / metabolism
  • Oxidative Stress / drug effects*
  • Phosphorylation
  • Proto-Oncogene Proteins c-jun / metabolism*
  • Rats
  • Rats, Wistar
  • Spin Labels
  • Time Factors

Substances

  • Biomarkers
  • Cyclic N-Oxides
  • Free Radical Scavengers
  • Proto-Oncogene Proteins c-jun
  • Spin Labels
  • Malondialdehyde
  • JNK Mitogen-Activated Protein Kinases
  • tempol